Who are Azenta, Inc.'s main suppliers?

Azenta, Inc. (AZTA) key suppliers include: B-MEDICAL-SYSTEMS-S-R-L, INTEGRATED-DNA-TECHNOLOGIES, UK-BIOCENTRE-LIMITED, MARAVAI-LIFESCIENCES-HOLDINGS-INC, THELEMA-S-R-L and 7 more. View the full supplier network at chainsifter.com/chain/AZTA.

Who are Azenta, Inc.'s major customers?

Azenta, Inc. (AZTA) key customers include: USGOV-DEPARTMENT-OF-HEALTH-AND-HUMAN-SERVICES, B-MEDICAL-SYSTEMS-SEGMENT, THELEMA-S-R-L, Manchester, Manchester and 16 more. View the full customer network at chainsifter.com/chain/AZTA.

What sector is Azenta, Inc. in?

Azenta, Inc. (AZTA) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

Azenta, Inc. Supplier List (AZTA): 12 Verified Suppliers

12Suppliers

21Customers

1Debt Items

20Related Chains

Source-Backed Evidence Depth

Azenta, Inc. (AZTA) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

35Total relationships

7Distinct source URLs

10High confidence

0.733Average confidence

2026-09-13Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Azenta, Inc. Suppliers

Ticker	Name	Confidence	Evidence
B-MEDICAL-SYSTEMS-S-R-L	B-MEDICAL-SYSTEMS-S-R-L	90%	Azenta Germany GmbH entered into a definitive Sale and Purchase Agreement with Thelema relating to the entire issued share capital of B Medical Systems S.À R.L.
INTEGRATED-DNA-TECHNOLOGIES	INTEGRATED-DNA-TECHNOLOGIES	90%	Mr. Martin joined Danaher in 2018 in connection with its acquisition of Integrated DNA Technologies ("IDT"), a supplier of custom nucleic acids, where he served as President of the IDT business under…
UK-BIOCENTRE-LIMITED	UK-BIOCENTRE-LIMITED	90%	Azenta UK Ltd. acquired all the issued and outstanding share capital of UK Biocentre, a provider of sample management, sample storage and high-throughput sample processing services
MARAVAI-LIFESCIENCES-HOLDINGS-INC	MARAVAI-LIFESCIENCES-HOLDINGS-INC	80%	Mr. Martin most recently served as Chief Executive Officer of Maravai LifeSciences Holdings, Inc. (Nasdaq: MRVI), a life sciences company providing products and services to enable the development of …
THELEMA-S-R-L	THELEMA-S-R-L	80%	Thelema is a private limited liability company incorporated under the laws of Luxembourg.
MANU	Manchester	72%	Reciprocal relationship from MANU graph: Reciprocal relationship from AZTA graph: n vector used in CGT. Furthermore, we continue to add value to drug discovery and development research by expanding o…
MANU	Manchester	72%	n vector used in CGT. Furthermore, we continue to add value to drug discovery and development research by expanding our portfolio to include proteomics solutions. We will continue to focus on develop…
TMO	Thermo Fisher Scientific Inc.	72%	que portfolio of products and services. Each segment, however, has unique competitors in their area of offerings. In the Sample Management Solutions segment, our main competitors include Hamilton Com…
TMO	Thermo Fisher Scientific Inc.	72%	Reciprocal relationship from TMO graph: Reciprocal relationship from AZTA graph: Reciprocal relationship from TMO graph: Reciprocal relationship from AZTA graph: Reciprocal relationship from TMO grap…
TWST	Twist Bioscience Corporation	72%	que portfolio of products and services. Each segment, however, has unique competitors in their area of offerings. In the Sample Management Solutions segment, our main competitors include Hamilton Com…
TWST	Twist Bioscience Corporation	72%	Reciprocal relationship from TWST graph: Reciprocal relationship from AZTA graph: que portfolio of products and services. Each segment, however, has unique competitors in their area of offerings. In …
DANAHER-CORPORATION	DANAHER-CORPORATION	70%	Mr. Martin was Senior Vice President, New Business—Genomic Medicine at Danaher Corporation (NYSE: DHR), a global science and technology company, from July 2021 to July 2022.

Azenta, Inc. Customers

Ticker	Name	Confidence	Evidence
USGOV-DEPARTMENT-OF-HEALTH-AND-HUMAN-SERVICES	USGOV-DEPARTMENT-OF-HEALTH-AND-HUMAN-SERVICES	95%	USAspending awards from Department of Health and Human Services: $4,302 across 1 awards. 75N95020P00106 BIOSTORE III CRYO -190C CRYOGENIC STORAGE SYSTEM WITH ACCESSORIES AND A SERVICE AGREEMENT. \| Qw…
B-MEDICAL-SYSTEMS-SEGMENT	B-MEDICAL-SYSTEMS-SEGMENT	92%	One customer accounted for 10 % and 13 % of the Company’s consolidated revenue for fiscal years 2024 and 2023 , respectively. This customer is related to the B Medical Systems segment and is a distri…
THELEMA-S-R-L	THELEMA-S-R-L	92%	Thelema is acquiring 100% of B Medical’s share capital for USD 63,000,000.
MANU	Manchester	72%	Reciprocal relationship from MANU graph: Reciprocal relationship from AZTA graph: Reciprocal relationship from MANU graph: Reciprocal relationship from AZTA graph: Reciprocal relationship from MANU g…
MANU	Manchester	72%	n vector used in CGT. Furthermore, we continue to add value to drug discovery and development research by expanding our portfolio to include proteomics solutions. We will continue to focus on develop…
TMO	Thermo Fisher Scientific Inc.	72%	Reciprocal relationship from TMO graph: Reciprocal relationship from AZTA graph: que portfolio of products and services. Each segment, however, has unique competitors in their area of offerings. In t…
TMO	Thermo Fisher Scientific Inc.	72%	que portfolio of products and services. Each segment, however, has unique competitors in their area of offerings. In the Sample Management Solutions segment, our main competitors include Hamilton Com…
TWST	Twist Bioscience Corporation	72%	que portfolio of products and services. Each segment, however, has unique competitors in their area of offerings. In the Sample Management Solutions segment, our main competitors include Hamilton Com…
TWST	Twist Bioscience Corporation	72%	Reciprocal relationship from TWST graph: Reciprocal relationship from AZTA graph: que portfolio of products and services. Each segment, however, has unique competitors in their area of offerings. In …
AMERICA-HOLDINGS	AMERICA-HOLDINGS	62%	ferings. In the Sample Management Solutions segment, our main competitors include Hamilton Company and Liconic AG for automation systems and Laboratory Corporation of America Holdings and Thermo Fish…
ATLAS-COPCO-GROUP	ATLAS-COPCO-GROUP	62%	statements. 10 Table of Contents AZENTA, INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited) 1. Nature of Operations Azenta, Inc. (“Azenta”, or the “Company”) is a leading global pr…
BARKEY-HOLDING-GMBH	BARKEY-HOLDING-GMBH	62%	Item 8, “Financial Statements and Supplementary Data” of this Annual Report on Form 10‑K. Within our Sample Management Solutions segment, we operate as a single business unit offering end-to-end samp…
BGI-GENOMICS-CO-LTD	BGI-GENOMICS-CO-LTD	62%	ferings. In the Sample Management Solutions segment, our main competitors include Hamilton Company and Liconic AG for automation systems and Laboratory Corporation of America Holdings and Thermo Fish…
BROOKS-AUTOMATION-INC	BROOKS-AUTOMATION-INC	62%	Item 1A “Risk Factors” below, as updated and/or supplemented in subsequent filings with the SEC. These and other factors could cause our future performance to differ materially from our assumptions a…
CAPITAL-RESOURCES	CAPITAL-RESOURCES	62%	Item 1 of this Quarterly Report on Form 10-Q for additional information. Income Tax Expense We rec orded income tax benefit of $0.3 million and income tax expense of $2.8 million, respectively, durin…
EDWARDS-VACUUM-LLC	EDWARDS-VACUUM-LLC	62%	ion in cash from our German subsidiary. We recorded a net tax benefit in the amount of $3.2 million related to the repatriation. The benefit included $5.2 million related to deductible U.S. foreign e…
LICONIC-AG	LICONIC-AG	62%	ferings. In the Sample Management Solutions segment, our main competitors include Hamilton Company and Liconic AG for automation systems and Laboratory Corporation of America Holdings and Thermo Fish…
MEDICAL-SYSTEMS-HOLDINGS	MEDICAL-SYSTEMS-HOLDINGS	62%	s Completed in Fiscal Year 2023 Ziath Ltd On February 2, 2023, the Company acquired Ziath, Ltd. and its subsidiaries (“Ziath”). Based in Cambridge, United Kingdom, Ziath is a leading provider of 2D b…
OPERATIONS-AZENTA-INC	OPERATIONS-AZENTA-INC	62%	, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS 1. Nature of Operations Azenta, Inc. (“Azenta”, or the “Company”) is a leading global provider of biological and chemical compound sample exploration…
UK-BIOCENTRE-LIMITED	UK-BIOCENTRE-LIMITED	62%	elopment and significantly accelerate time to market for our life sciences solutions. Acquisition of UK Biocentre On March 4, 2026, we acquired UK Biocentre Limited, or UK Biocentre, for a purchase p…
ZIATH-LTD	ZIATH-LTD	62%	s Completed in Fiscal Year 2023 Ziath Ltd On February 2, 2023, the Company acquired Ziath, Ltd. and its subsidiaries (“Ziath”). Based in Cambridge, United Kingdom, Ziath is a leading provider of 2D b…

Azenta, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
AZTA-DEBT	Debt stack $50.1M	90%	Market cache reports total debt of $50.1M.

Azenta, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Azenta, Inc..

Azenta, Inc. Ownership

Holder	Name	Confidence	Evidence
AZTA-OWNER-BLACKROCK-INC	BlackRock, Inc.	90%	13F overlay lists BlackRock, Inc. as top holder; 263 tracked holders.

Azenta, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops
GVH	Globavend Holdings Limited	100.00	2
GGB	Gerdau S.A.	100.00	2
CLLS	Cellectis S.A.	100.00	2
DOYU	DouYu International Holdings Limited	100.00	2
ICLR	ICON Public Limited Company	100.00	2
IDXG	Interpace Biosciences, Inc.	100.00	2
AAUAF	Almaden Minerals Ltd.	100.00	2
BHPLF	BHP Group Limited	100.00	2
DGNX	Diginex Limited	100.00	2
BNRG	Brenmiller Energy Ltd	100.00	2
RYAOF	Ryanair Holdings plc	100.00	2
BANL	CBL International Limited	100.00	2
CBAN	Colony Bankcorp, Inc.	100.00	2
ALCY	Alchemy Investments Acquisition Corp 1	100.00	2
ALGM	Allegro MicroSystems, Inc.	100.00	2
AUGO	Aura Minerals Inc.	100.00	2
GRAL	GRAIL, Inc.	100.00	2
ACET	Adicet Bio, Inc.	100.00	2
BTAI	BioXcel Therapeutics, Inc.	100.00	2
GH	Guardant Health, Inc.	100.00	2

Azenta, Inc. Supply Chain